- active not recruitingPHASE2
Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis
This study is looking into a new medication called RXC007 for Idiopathic Pulmonary Fibrosis (IPF). Researchers want to see if it's safe, how it works in the body, and if it helps patients with IPF. It involves taking the medication or a placebo for 12 weeks.
Austria · Belgium · Czechia - recruitingPHASE1
Phase I Study to Assess Safety, Tolerability, PK and PD of AGMB-447 in Healthy Participants and Participants With IPF
This study is testing a new inhaled medicine, AGMB-447, for idiopathic pulmonary fibrosis (IPF). Researchers want to see if it's safe and how it works in healthy volunteers and people with IPF. It's an early-stage trial comparing the medicine to a dummy treatment (placebo).
United Kingdom